NEOLA.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$12M	-2.4%	$-0.20	$-0.20–$-0.20	—	1
2027	$13M	+9.9%	$0.00	$0.00–$0.00	—	0
2028	$16M	+19.5%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$0.21

Price

$0.53

Implied downside

-61%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
NEOLA.STNeola Medical AB (publ)	$0.53	-1.87%	$58M	—
ACUC.STAcuCort AB	$0.55	+3.00%	$129M	—
ARCOMA.STArcoma AB	$7.96	-4.10%	$114M	—
BRAIN.STBrainCool AB (publ)	$0.94	+1.96%	$369M	—
CMOTEC-B.STScandinavian ChemoTech AB (publ)	$3.67

Neola Medical AB (publ)

Neola Medical AB (publ) specializes in developing advanced medical devices for the continuous pulmonary assessment of premature babies. At the core of its offerings is NEOLA, a sophisticated medical instrument critical for neonatal intensive care. This device facilitates ongoing lung function monitoring and generates immediate alerts for critical, life-threatening complications. It achieves this by accurately tracking changes in lung volume and oxygen gas concentration. The ultimate goal of NEOLA is to enhance intensive care and promote healthier outcomes for infants born preterm. The company, formerly known as GPX Medical AB, officially changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was established in 2016 and is headquartered in Lund, Sweden.

www.neolamedical.com

Employees: 9
IPO / List date: Oct 2, 2020
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds NEOLA.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in NEOLA.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded NEOLA.ST yet.